Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Eledon Pharmaceuticals Inc (ELDN)

Eledon Pharmaceuticals Inc (ELDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Eledon Pharmaceuticals Inc 19800 MACARTHUR BOULEVARD SUITE 250 IRVINE CA 92612 USA

www.eledon.com Employees: 31 P: 949-238-8090

Sector:

Medical

Description:

Eledon Pharmaceuticals Inc. is a clinical stage biotechnology company. It develop treatments for an organ or cell-based transplant, and for people with autoimmune and neurodegenerative disease. Eledon Pharmaceuticals Inc., formerly known as Novus Therapeutics Inc., is based in IRVINE, Calif.

Key Statistics

Overview:

Market Capitalization, $K 125,258
Enterprise Value, $K 104,708
Shares Outstanding, K 59,932
Float, K 52,560
% Float 87.70%
Short Interest, K 6,323
Short Float 10.55%
Days to Cover 7.31
Short Volume Ratio 0.63
% of Insider Shareholders 12.30%
% of Institutional Shareholders 56.77%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -36,180 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -17,460 K
EBIT, $ -86,460 K
EBITDA, $ -88,900 K

Growth:

1-Year Return -53.35%
3-Year Return -23.77%
5-Year Return -89.20%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 99.95%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.21 on 11/14/25
Next Earnings Date 03/19/26
Earnings Per Share ttm -1.06
EPS Growth vs. Prev Qtr -61.54%
EPS Growth vs. Prev Year 34.38%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-18 on 10/05/20

ELDN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -154.16%
Return-on-Assets % -52.02%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 3.61
Book Value/Share 1.52
Interest Coverage -0.92
60-Month Beta 0.89
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar